Table 2.

Hospital Admission Diagnoses Between 4.5 and 9 Months of Age, by Sex and Vaccination Group

Diagnosis	Admitted Children, No., by Sex and Vaccination Group (No NVAS; NVAS)							Admission HRR (95% CI)
	Boys		Girls		All		All Admissions	No NVAS	NVAS
	Early Recipients (n = 1084)	Controls (n = 2151)	Early Recipients (n = 1045)	Controls (n = 2137)	Early Recipients (n = 2129)	Controls (n = 4288)
Pneumonia/ respiratory infection	15 (6; 9)	24 (14; 10)	5 (0; 5)	33 (19; 14)	20 (6; 14)	57 (33; 24)	0.71 (0.42–1.17)	0.37 (0.16–0.89)	1.15 (0.59–2.21)
Diarrhea and dysentery	7 (3; 4)	11 (8; 3)	3 (2; 1)	4 (2; 2)	10 (5; 5)	15 (10; 5)	1.35 (0.60–3.00)	1.05 (0.36–3.06)	1.94 (0.56–6.71)
Malaria, anemia	12 (6; 6)	39 (19; 20)	10 (4; 6)	31 (14; 17)	22 (10; 12)	70 (33; 37)	0.64 (0.39–1.03)	0.62 (0.31–1.26)	0.65 (0.34–1.24)
Measles	0	9 (4; 5)	0	8 (6; 2)	0	17 (10; 7)	0 (0–0.24)	0 (0–0.44)	0 (0–0.61)
Othera	3 (2; 1)	3 (1; 2)	2 (0; 2)	2 (2; 0)	5 (2; 3)	5 (3; 2)	2.05 (0.59–7.10)	1.38 (0.23–8.27)	3.05 (0.51–18.25)
All	37 (17; 20)	86 (46; 40)	20 (6; 14)	78 (43; 35)	57 (23; 34)	164 (89; 75)	0.70 (0.52–0.95)	0.53 (0.34–0.84)	0.90 (0.60–1.35)

Data are from the national pediatric ward, Guinea-Bissau. Early recipients received measles vaccine at 4.5 and 9 months of age, and controls received vaccine at 9 months of age.

Abbreviations: CI, confidence interval; HRR, hazard rate ratio; NVAS, neonatal vitamin A supplementation.

^a Chicken pox (1 case), malnutrition (1), sepsis (2), febrile syndrome (2), throat abscess (2), impetigo (1), and intoxication (1).